Ozempic vs Wegovy
One of the most-searched GLP-1 questions, with a surprising answer: Ozempic and Wegovy are the same molecule, semaglutide, from the same manufacturer. What differs is what they're approved for and how high they're dosed — which determines which one you should be prescribed.
Last reviewed 2026-09-01 by the TopGLP1 Editorial Team
Educational, not medical advice. This page explains GLP-1 medications in general terms. Only a licensed clinician who knows your history can decide what's right for you.
For weight loss specifically, Wegovy is the right product — it's FDA-approved for weight management and dosed higher (up to 2.4 mg). Ozempic is the same drug approved for type 2 diabetes.
Choose Ozempic if…
you have type 2 diabetes — Ozempic is the approved and commonly covered option.
Choose Wegovy if…
your goal is weight loss — Wegovy is the approved, higher-dose product for that.
Side by side
| Ozempic | Wegovy | |
|---|---|---|
| Active molecule | Semaglutide | Semaglutide |
| FDA-approved for | Type 2 diabetes | Chronic weight management |
| Max dose | 2.0 mg weekly | 2.4 mg weekly |
| Route | Weekly injection | Weekly injection |
| Avg. weight loss | Meaningful, but dosed for glucose | ~15% (STEP 1) |
| Insurance coverage | Often covered (diabetes) | Often excluded (weight loss) |
How they compare on results
Because they're the same molecule, the biology is identical. The practical differences are dose and indication: Wegovy goes up to 2.4 mg and is studied and approved specifically for weight management (about 15% average loss in STEP 1), while Ozempic tops out at 2.0 mg and is approved for type 2 diabetes.
This is why people are sometimes prescribed Ozempic 'off-label' for weight loss — but Wegovy is the on-label, higher-dose product for that goal, and using the right one can matter for both results and insurance.
Side effects & safety
Identical safety profile — they're the same drug: GI side effects during escalation, and the same pancreatitis, gallbladder and thyroid C-cell warnings.
Cost
Both are branded and expensive without insurance (~$1,000+/mo). Coverage is more common for Ozempic (diabetes) than Wegovy (weight loss). Compounded semaglutide is the low-cost alternative to either.
Full drug guides
Ozempic vs Wegovy: common questions
Sources & references
Clinical figures on this page trace to peer-reviewed trials and official regulators. We link the primary record so you can verify it yourself.
- 1.Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989–1002.Clinical trialNew England Journal of Medicine
- 2.Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221–2232.Clinical trialNew England Journal of Medicine